NCT02324296 2025-06-11
PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases
Azienda USL Reggio Emilia - IRCCS
Completed
Clinical Trials
7 trialsNCT00003657 2017-01-20
High-dose ICE With Amifostine
Dana-Farber Cancer Institute
Phase 2 Completed
NCT01784107 2016-02-10
A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer
Gachon University Gil Medical Center
Phase 1/2 Unknown
NCT00658580 2015-02-12
Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer
European Lung Cancer Working Party
Phase 3 Completed
NCT00003284 2014-01-06
High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00004186 2013-04-12
Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
University of Alabama at Birmingham
Phase 1/2 Completed
NCT01752517 2012-12-19
Vinorelbine and Ifosfamide as Third-line Treatment for Refractory Small Cell Lung Cancer
Peking Union Medical College Hospital
Unknown